联合粪便血红蛋白、缺铁性贫血状态与年龄可改善初级保健肠道症状患者结直肠癌风险预测:一项回顾性观察研究
该回顾性单中心观察研究纳入2015年12月至2019年12月间同时提交粪便血红蛋白与全血细胞计数样本的有症状患者,按缺铁性贫血状态分组,通过链接苏格兰癌症登记处识别结直肠癌。联合粪便血红蛋白、年龄与缺铁性贫血状态可改善结直肠癌风险预测,并识别出粪便血红蛋白<20 µg Hb/g且无缺铁性贫血的低风险组。
要点
- 粪便血红蛋白>99 µg Hb/g且年龄>40岁患者结直肠癌风险超过3%。
- 粪便血红蛋白>99 µg Hb/g且年龄>55岁合并缺铁性贫血者结直肠癌风险达30%(19.4-41.0)。
- 粪便血红蛋白10-19 µg Hb/g且年龄<85岁无缺铁性贫血者结直肠癌风险未超过3%。
核心结论
- 联合粪便血红蛋白、患者年龄与缺铁性贫血状态可改善结直肠癌风险预测,识别出粪便血红蛋白<20 µg Hb/g且无缺铁性贫血的低风险组,并可为修订转诊指南提供依据。
研究设计与样本
- 回顾性单中心观察研究,纳入2015年12月至2019年12月间同时提交粪便血红蛋白与全血细胞计数样本的有症状患者。
- 粪便血红蛋白采用HM-JACKarc(Hitachi Chemical Diagnostics Systems)检测,按缺铁性贫血存在与否分组,通过链接苏格兰癌症登记处识别结直肠癌。
- 采用Kaplan-Meier法估计按年龄、粪便血红蛋白结果及缺铁性贫血状态分层的1年累积结直肠癌风险。
主要发现
- 共获取34 647份有效粪便血红蛋白结果,其中7889份(22.8%)粪便血红蛋白≥10 µg Hb/g。
- 上述样本中33 285份(96.1%)有相关全血细胞计数结果,其中3000份(9.0%)存在缺铁性贫血。
- 共记录571例新发结直肠癌。
- 粪便血红蛋白>99 µg Hb/g且年龄>40岁患者结直肠癌风险超过3%;粪便血红蛋白>99 µg Hb/g且年龄>55岁合并缺铁性贫血者风险达30%(19.4-41.0)。
- 2029份粪便血红蛋白结果(25.7%)位于10-19 µg Hb/g范围,其中27份(1.3%)检出结直肠癌;该亚组中年龄<85岁且无缺铁性贫血者结直肠癌风险未超过3%。
关键数值与推荐
- 英国国家卫生与临床优化研究所疑似癌症指南推荐:疑似结直肠癌时应检测粪便血红蛋白,转诊阈值为≥10 µg Hb/g粪便,定义3%风险。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In primary care, National Institute for Health and Care Excellence suspected cancer guidelines recommend measuring faecal haemoglobin (f-Hb) if colorectal cancer (CRC) is suspected, with a referral threshold of ≥10 µg Hb/g faeces defining a 3% risk, but most have a normal colonoscopy. OBJECTIVE: Examine whether combining f-Hb, patient age and iron-deficient anaemia (IDA) status improves risk prediction. DESIGN: Retrospective single-centre observational study of symptomatic patients who submitted contemporaneous f-Hb and full blood count (FBC) samples between December 2015 and December 2019. f-Hb was estimated using HM-JACKarc (Hitachi Chemical Diagnostics Systems). Patients were categorised by presence/absence of IDA. Incident CRC was identified via record linkage to the Scottish Cancer Registry. Kaplan-Meier estimates determined cumulative 1-year CRC risk by patient age, f-Hb result and presence of IDA. RESULTS: Of 34 647 valid f-Hb results retrieved; 7889 (22.8%) had f-Hb≥10 µg Hb/g. Of these, 33 285 samples (96.1%) had associated FBC results of which 3000 (9.0%) had IDA. Overall, 571 incident CRC were recorded. The risk of CRC breached 3% in patients with f-Hb>99 µg Hb/g aged >40 years and reached 30% (19.4-41.0) with f-Hb>99 µg Hb/g in age >55 years plus IDA. 2029 f-Hb results (25.7%) were in the 10-19 µg Hb/g range of which 27 (1.3%) had CRC. In this subgroup, CRC risk did not exceed 3% in patients <85 years and no IDA. CONCLUSION: Combining f-Hb, patient age and IDA status improves CRC risk prediction, identifies a low-risk group with f-Hb<20 µg Hb/g and no IDA and could inform revised referral guidance.
引用
- Digby J, Nobes J, Strachan JA, et al. Combining faecal haemoglobin, iron deficiency anaemia status and age can improve colorectal cancer risk prediction in patients attending primary care with bowel symptoms: a retrospective observational study. Gut. 2025. PMID: 40139747. doi:10.1136/gutjnl-2024-334248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。